Ben Gigliotti is an Assistant Professor in the Department of Medicine, Endocrine/Metabolism (SMD) at University of Rochester Medical Center. He received his undergraduate and medical degrees from the University of Rochester, where he stayed on to train as a resident in internal medicine and to subsequently serve as chief resident. He completed his fellowship at Massachusetts General Hospital and then returned to the University of Rochester to join the faculty in the Endocrine Division.

Dr. Gigliotti’s clinical interests are in general endocrinology and internal medicine, including diabetes and thyroid, parathyroid, adrenal, pituitary, and reproductive diseases. He has a particular interest in the care of patients with thyroid disorders including hyperthyroidism, hypothyroidism, thyroid nodules, thyroid cancer, other endocrine cancers and hereditary syndromes. His research focus is on the bench to bedside development of novel treatments and combination regimens for patients with advanced thyroid cancers, including the use of small molecule inhibitors and immunotherapies and studying the role of molecular and microenvironmental profiling to inform therapy.

Representative Publications:

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

PD-L1 and IDO1 are Expressed in Poorly Differentiated Thyroid Carcinoma

Circulating BRAFV600E Levels Correlate With Treatment in Patients With Thyroid Carcinoma

In Vivo Prostaglandin E2 Treatment Alters the Bone Marrow Microenvironment and Preferentially Expands Short-Term Hematopoietic Stem Cells

Share

Discuss in Social Wall

Twitter

Share to rareTeam

myBinder